No special license or certification is legally required to prescribe semaglutide
These variable responses are consistent with GI adverse reactions documented in the SmPCs for approved GLP-1-based medicines (see, for example, the EMC SmPCs for Wegovy and Mounjaro)
Left untreated, many of these conditions can reduce energy and tolerance of physical activity, Maselli says
It is still the only oral GLP-1 on the market for type 2 diabetes, and in 2025, semaglutide in a pill was approved in the US as first oral GLP-1 for weight management
By 2050, 1.31 billion people may develop type 2 diabetes worldwide
When to Speak to Your GP About Urinary Changes You should contact your healthcare provider if you experience any of the following: Signs of uncontrolled blood sugar: Increased urination combined with excessive thirst Unexplained weight loss despite good appetite Persistent fatigue or blurred vision These symptoms suggest your diabetes may not be adequately controlled and your treatment plan may need adjustment